These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2086280)

  • 1. [Feasibility and acceptability of insulin therapy using a pen suitable for injecting regular or intermediate insulin. Results of the French multicenter study conducted by the Optipen-France Study Group].
    Pinget M; Vexiau P; Sandre D; Pasqual C; Weisselberg C
    Diabete Metab; 1990 Dec; 16(6):492-7. PubMed ID: 2086280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Injection aids for intermediate-term acting insulin. Experiences with the OptiPen].
    Schifferdecker E; Jungmann E; Schöffling K
    Fortschr Med; 1989 May; 107(15):348-50. PubMed ID: 2737581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability and safety of a new 3.0 ml re-usable insulin pen (HumaPen) in clinical use.
    Martin JM; Llewelyn JA; Ristic S; Bates PC
    Diabetes Nutr Metab; 1999 Oct; 12(5):306-9. PubMed ID: 10741343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient acceptability of a new 3.0 ml pre-filled insulin pen.
    D'Eliseo P; Blaauw J; Milicević Z; Wyatt J; Ignaut DA; Malone JK
    Curr Med Res Opin; 2000; 16(2):125-33. PubMed ID: 10893656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient acceptance and reliability of new Humulin/Humalog 3.0 ml prefilled insulin pen in ten Croatian diabetes centres.
    Sucic M; Galic E; Cabrijan T; Ivandic A; Petrusic A; Wyatt J; Mincheva N; Milicevic Z; Malone J
    Med Sci Monit; 2002 Mar; 8(3):PI21-6. PubMed ID: 11884952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functionality and acceptability of a new electronic insulin injection pen with a memory feature.
    Venekamp WJ; Kerr L; Dowsett SA; Johnson PA; Wimberley D; McKenzie C; Malone J; Milicevic Z
    Curr Med Res Opin; 2006 Feb; 22(2):315-25. PubMed ID: 16466603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
    Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
    Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe.
    Stockl K; Ory C; Vanderplas A; Nicklasson L; Lyness W; Cobden D; Chang E
    Curr Med Res Opin; 2007 Jan; 23(1):133-46. PubMed ID: 17257475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of diabetes mellitus in hospitalized patients: efficiency and effectiveness of sliding-scale insulin therapy.
    Golightly LK; Jones MA; Hamamura DH; Stolpman NM; McDermott MT
    Pharmacotherapy; 2006 Oct; 26(10):1421-32. PubMed ID: 16999652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
    Hassan K; Rodriguez LM; Johnson SE; Tadlock S; Heptulla RA
    Pediatrics; 2008 Mar; 121(3):e466-72. PubMed ID: 18299307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of usability and patient preference for the new disposable insulin device Solostar versus Flexpen, lilly disposable pen, and a prototype pen: an open-label study.
    Haak T; Edelman S; Walter C; Lecointre B; Spollett G
    Clin Ther; 2007 Apr; 29(4):650-60. PubMed ID: 17617288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does an insulin pen improve the metabolic control of type 1 diabetes mellitus if added to conventional treatment?
    Roos AN; Meinders AE
    Neth J Med; 1989 Apr; 34(3-4):116-25. PubMed ID: 2657451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled human insulin: new drug. No short-term advantages, too many unknowns in the long term.
    Prescrire Int; 2006 Dec; 15(86):203-9. PubMed ID: 17165235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
    Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.
    Lee WC; Balu S; Cobden D; Joshi AV; Pashos CL
    Clin Ther; 2006 Oct; 28(10):1712-25; discussion 1710-1. PubMed ID: 17157128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in health-related quality of life, independent of fasting glucose concentration, via insulin pen device in diabetic patients.
    Lee IT; Liu HC; Liau YJ; Lee WJ; Huang CN; Sheu WH
    J Eval Clin Pract; 2009 Aug; 15(4):699-703. PubMed ID: 19674222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Patient acceptance of NovoLet--an integrated insulin dosage system for repeated use. A multicenter study].
    Laursen HB
    Ugeskr Laeger; 1991 Aug; 153(35):2416-9. PubMed ID: 1949241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preprandial combination of lispro and NPH insulin improves overall blood glucose control in type 1 diabetic patients: a multicenter randomized crossover trial.
    Annuzzi G; Del Prato S; Arcari R; Bellomo Damato A; Benzi L; Bruttomesso D; Calderini MC; Coscelli C; Fedele D; Galluzzo A; Giordano M; Giorgino R; Lapolla A; Orsini P; Pagano G; Santoro D; Riccardi G
    Nutr Metab Cardiovasc Dis; 2001 Jun; 11(3):168-75. PubMed ID: 11590992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Insuject-X for children. A clinical trial of the NPH insulin pen].
    Rix M; Voght H; Nielsen K; Jakobsen G; Holsteen V
    Ugeskr Laeger; 1990 Apr; 152(15):1086-9. PubMed ID: 2184557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multiple insulin injections with the help of a subcutaneous catheter or metered syringe (Pen)].
    Tatoń J; Czech A; Jagielińska-Kalinowska E
    Pol Tyg Lek; 1991 Oct 28-Nov 4; 46(43-44):834-7. PubMed ID: 1669173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.